Characteristics | % patients (n = 44*) | Global polyuria | p-value** (c2) | |
or Mean ± SD | Absent (n = 38) | Present (n = 6) | ||
Location |
|
|
|
|
Niterói | 36.4 | 87.5 | 12.5 | 1.000 |
Petrópolis | 63.6 | 85.7 | 14.3 | |
Age |
|
|
|
|
Less than 60 years old | 38.6 | 88.2 | 11.8 | 1.000 |
60 years or older | 61.4 | 85.2 | 14.8 | |
Education |
|
|
|
|
Up to incomplete primary school | 50.0 | 86.4 | 13.6 | 1.000 |
At least completed primary school | 50.0 | 86.4 | 13.6 | |
Hesitation |
|
|
|
|
Absent | 88.6 | 84.6 | 15.4 | 0.801 |
Present | 11.4 | 100.0 | 0.0 | |
Slow stream |
|
|
|
|
Absent | 75.0 | 84.8 | 15.2 | 1.000 |
Present | 25.0 | 90.9 | 9.1 | |
Feeling of incomplete bladder emptying |
|
|
|
|
Absent | 29.5 | 100.0 | 0.0 | 0.220 |
Present | 70.5 | 80.6 | 19.4 | |
Post-voiding incontinence |
|
|
|
|
Absent | 61.4 | 85.2 | 14.8 | 1.000 |
Present | 38.6 | 88.2 | 11.8 | |
Pelvic organ prolapse (symptom) |
|
|
|
|
Absent | 70.5 | 87.1 | 12.9 | 1.000 |
Present | 29.5 | 84.6 | 15.4 | |
Anterior vaginal wall prolapse |
|
|
|
|
Up to stage II | 93.2 | 85.4 | 14.6 | 1.000 |
Stage III ou IV | 6.8 | 100.0 | 0.0 | |
Posterior vaginal wall prolapse |
|
|
|
|
Up to stage II | 97.7 | 86.0 | 14.0 | 1.000 |
Stage III ou IV | 2.3 | 100.0 | 0.0 | |
Apical prolapse |
|
|
|
|
Up to stage II | 97.7 | 86.0 | 14.0 | 1.000 |
Stage III ou IV | 2.3 | 100.0 | 0.0 | |
Fecal incontinence |
|
|
|
|
Absent | 90.9 | 85.0 | 15.0 | 0.945 |
Present | 9.1 | 100.0 | 0.0 | |
Constipation (Bristol stool scale) |
|
|
|
|
Absent | 77.3 | 88.2 | 11.8 | 0.886 |
Present | 22.7 | 80.0 | 20.0 | |
Constipation (frequency of bowel movements) |
|
|
|
|
Absent | 75.0 | 90.9 | 9.1 | 0.310 |
Present | 25.0 | 72.7 | 27.3 | |
Recurrent urinary tract infection |
|
|
|
|
Absent | 81.8 | 91.7 | 8.3 | 0.109 |
Present | 18.2 | 62.5 | 37.5 | |
Systemic arterial hypertension |
|
|
|
|
Absent | 40.9 | 88.9 | 11.1 | 1.000 |
Present | 59.1 | 84.6 | 15.4 | |
Diabetes mellitus |
|
|
|
|
Absent | 63.6 | 85.7 | 14.3 | 1.000 |
Present | 36.4 | 87.5 | 12.5 | |
Heart failure |
|
|
|
|
Absent | 97.7 | 86.0 | 14.0 | 1.000 |
Present | 2.3 | 100.0 | 0.0 |
|
Chronic kidney disease |
|
|
|
|
Absent | 93.2 | 87.8 | 12.2 | 0.874 |
Present | 6.8 | 66.7 | 33.3 | |
Chronic venous insufficiency |
|
|
|
|
Absent | 68.2 | 90.0 | 10.0 | 0.577 |
Present | 31.8 | 78.6 | 21.4 | |
Depression/Anxiety |
|
|
|
|
Absent | 81.8 | 88.9 | 11.1 | 0.641 |
Present | 18.2 | 75.0 | 25.0 | |
Number of comorbidities |
|
|
|
|
Up to 2 comorbidities | 22.7 | 100.0 | 0.0 | 0.365 |
3 or more | 77.3 | 82.4 | 17.6 | |
Antidepressant |
|
|
|
|
Absent | 77.3 | 88.2 | 11.8 | 0.886 |
Present | 22.7 | 80.0 | 20.0 | |
Diuretic |
|
|
|
|
Absent | 72.7 | 84.4 | 15.6 | 0.893 |
Present | 27.3 | 91.7 | 8.3 | |
Calcium channel blocker |
|
|
|
|
Absent | 75.0 | 81.8 | 18.2 | 0.310 |
Present | 25.0 | 100.0 | 0.0 | |
Benzodiazepine |
|
|
|
|
Absent | 86.4 | 84.2 | 15.8 | 0.684 |
Present | 13.6 | 100.0 | 0.0 | |
Angiotensin II receptor blocker |
|
|
|
|
Absent | 61.4 | 85.2 | 14.8 | 1.000 |
Present | 38.6 | 88.2 | 11.8 | |
Beta-blocker |
|
|
|
|
Absent | 84.1 | 86.5 | 13.5 | 1.000 |
Present | 15.9 | 85.7 | 14.3 | |
Hypoglycemic agent |
|
|
|
|
Absent | 63.6 | 85.7 | 14.3 | 1.000 |
Present | 36.4 | 87.5 | 12.5 | |
Insulin |
|
|
|
|
Absent | 95.5 | 90.5 | 9.5 | 0.010 |
Present | 4.5 | 0.0 | 100.0 | |
Angiotensin-converting enzyme inhibitor |
|
|
|
|
Absent | 90.9 | 85.0 | 15.0 | 0.945 |
Present | 9.1 | 100.0 | 0.0 | |
Polypharmacy |
|
|
|
|
Up to 4 medications | 59.1 | 92.3 | 7.7 | 0.350 |
5 or more medications | 40.9 | 77.8 | 22.2 | |
Body mass index |
|
|
|
|
Normal | 18.2 | 62.5 | 37.5 | 0.018 |
Overweight | 31.8 | 78.6 | 21.4 | |
Obesity | 50.0 | 100.0 | 0.0 | |
Risk of obstructive sleep apnea |
|
|
|
|
Low | 34.1 | 80.0 | 20.0 | 0.674 |
Moderate or high | 65.9 | 89.7 | 10.3 | |
Stress urinary incontinence |
|
|
|
|
Absent | 86.4 | 86.8 | 13.2 | 1.000 |
Present | 13.6 | 83.3 | 16.7 | |
Urgency urinary incontinence |
|
|
|
|
Absent | 90.9 | 85.0 | 15.0 | 0.945 |
Present | 9.1 | 100.0 | 0.0 | |
Mixed urinary incontinence |
|
|
|
|
Absent | 27.3 | 91.7 | 8.3 | 0.893 |
Present | 72.7 | 84.4 | 15.6 | |
Overactive bladder syndrome |
|
|
|
|
Absent | 13.6 | 83.3 | 16.7 | 1.000 |
Present | 86.4 | 86.8 | 13.2 | |
Quantitative characteristics: |
|
|
|
|
Caffeine (mg/day)*** | 151.9 ± 65.7 | 153.0 ± 62.5 | 142.0 ± 89.6 | 0.538 |
Tobacco (packs/year)*** | 4.8 ± 11.8 | 3.7 ± 8.8 | 12.1 ± 23.6 | 0.037 |